SUPN icon

Supernus Pharmaceuticals
SUPN

Overview Fund Activity

208 hedge funds and large institutions have $895M invested in Supernus Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 66 increasing their positions, 87 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
208
Holders Change
-27
Holders Change %
-11.49%
% of All Funds
4.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
66
Reduced
87
Closed
47
Calls
$2.35M
Puts
$2.36M
Net Calls
-$3K
Net Calls Change
-$863K

Top Buyers

1
AC
Armistice Capital
New York
+$23.2M
2
Citadel Advisors
Citadel Advisors
Florida
+$7.77M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$6.24M
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$4.5M
5
Macquarie Group
Macquarie Group
Australia
+$4M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$20.4M
2
RCAMU
Rothschild & Co Asset Management US
Connecticut
-$17.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.04M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$4.65M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$4.63M
Name Holding Trade Value Shares
Change 		Shares
Change %
TFGT
251
TS Financial Group (TSFG)
Illinois
– -$1K -31 Closed
ASN
252
Advisory Services Network
Georgia
– -$1K -24 Closed
7 8 9 10
11